Clinical Trial Update: Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis [NA]

View source ↗

Summary

A clinical trial update describes an evaluation of vedolizumab combined with upadacitinib for ulcerative colitis, with study status currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (upadacitinib)
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Ulcerative Colitis (UC) | NA | Status: RECRUITING